fbpx

News

The Augurex team brings together leading scientific, clinical, technical and commercial expertise to ensure that our research translates into advanced diagnostics for improved patient outcomes.

Prev Next
Augurex Achieves MDSAP Certification

Augurex Achieves MDSAP Certification

Vancouver, BC – August 22, 2024 – Augurex Life Sciences Corp., a leader in biomarker-driven diagnostic solutions for the detection and management of autoimmune diseases, today announced its successful certification under the Medical Device Single Audit Program...

read more
Augurex to Present Two Posters at ADLM 2024 in Chicago

Augurex to Present Two Posters at ADLM 2024 in Chicago

Vancouver, Canada – July 26, 2024 – Augurex Life Sciences Corp. is pleased to announce that it will be presenting two posters at the upcoming Association for Diagnostic & Laboratory Medicine (ADLM 2024) in Chicago. The event will be held from July 28 to August 1,...

read more
Augurex Achieves MDSAP Certification

Augurex Achieves MDSAP Certification

Vancouver, BC – August 22, 2024 – Augurex Life Sciences Corp., a leader in biomarker-driven diagnostic solutions for the detection and management of autoimmune diseases, today announced its successful certification under the Medical Device Single Audit Program...

read more
New Day Diagnostics Collaboration

New Day Diagnostics Collaboration

Augurex and New Day Diagnostics Collaborate to Launch SPINEstat™, Revolutionizing Early Diagnosis and Management of Ankylosing Spondylitis Augurex and New Day Diagnostics Collaborate to Launch SPINEstat™, Revolutionizing Early Diagnosis and Management of Ankylosing...

read more
Augurex has received $5M in funding from PacifiCan

Augurex has received $5M in funding from PacifiCan

Government of Canada invests almost $14 million to drive innovation and economic growth in Vancouver.Today, the Honourable Mary Ng, Minister of Export Promotion, International Trade and Economic Development on behalf of the Honourable Harjit S. Sajjan, Minister of...

read more
Augurex to Present Two Posters at ADLM 2024 in Chicago

Augurex to Present Two Posters at ADLM 2024 in Chicago

Vancouver, Canada – July 26, 2024 – Augurex Life Sciences Corp. is pleased to announce that it will be presenting two posters at the upcoming Association for Diagnostic & Laboratory Medicine (ADLM 2024) in Chicago. The event will be held from July 28 to August 1,...

read more
Augurex and Quidel at ACR

Augurex and Quidel at ACR

Augurex and Quidel are pleased to announce the launch of the JOINTstat® 14-3-3η RUO (research use only) ELISA. This new distribution arrangement will get 14-3-3η testing into the hands of more investigators worldwide, including key opinion leaders and pharmaceutical...

read more
B.C.’s Most Influential Women 2018: Stem Stars

B.C.’s Most Influential Women 2018: Stem Stars

Working in STEM means that you’re innovative, you’re creative, you’re passionate, you’re clever, you’re whoever you want to be. We're so proud of our CEO Norma Biln being recognized by BC Business as a vital contributor to Women in Tech: [button...

read more
Augurex Presenting at World Congress on Inflammation

Augurex Presenting at World Congress on Inflammation

At the 12th World Congress on Inflammation in Boston from August 8-12, Dr. Anthony Marotta will be co-chairing Symposium #29: Biomarkers in Inflammation: Focus on Rheumatoid Arthritis and will be delivering the following two presentations alongside presenter and...

read more

Sign Up for Updates

* indicates required
Terms

Home

Products

Science

About

News

Careers

Contact

220 – 887 Great Northern Way
Vancouver, BC, V5T 4T5

Phone: 604.637.3280